Oracle's record quarter in Japan shows the underlying AI and cloud business is accelerating even while the macro backdrop — surging bond yields and higher oil — has knocked the US share price down. Goldman's regional strategist explicitly argues the AI in

Verdict: Oracle's earnings strength is real, but this dip-buy has not armed yet

The idea's core claim — that Oracle's selloff is macro, not a demand problem — gets genuine support from the quarter ended August 31, 2026: revenue of $19.4B grew 21% year over year (roughly the 75th percentile of the sector), operating margin expanded to about 35% (near the 97th percentile), and operating cash flow jumped 58% to $23.1B, while CNBC reported Oracle's Japan-listed shares surged 7% on a record quarter per its September 25, 2026 report. But the strongest point against is just as real: free cash flow deteriorated to negative $5.4B from negative $1.9B the prior quarter, was negative $23.7B for the fiscal year ended May 31, 2026, and a disclosure covering the period ended June 30, 2026 — a delayed look at positioning, not current data — shows 25 holders net selling roughly $45 million on the open market. Compounding the caution, this is a watch-list setup, not an active signal: the entry sequence (RSI back below 30 then above 40, a reclaim of the $148 50-day EMA, price above the $173 200-day EMA, QQQ holding its 50-day) has not triggered once in 1,235 evaluated daily bars over 60 months, and no robust alternative parameter setup was established because the sensitivity evaluation ran out of time. Right now ORCL sits at $137, about $36 below the 200-day EMA, so even the first step — a 1.7-point RSI drop below 30 — leads to a sequence that realistically needs an extended stabilization to complete. The verdict: keep this on watch; the fundamentals justify patience, but the trade does not exist until the conditions fire. The fact that would flip the verdict to buy is the full entry sequence arming — most immediately ORCL's RSI closing below 30 — alongside the next quarterly report showing free cash flow improving rather than deepening its burn.

Trade now: ORCL is in the dip, but the entry is not armed

ORCL closed at $137, sitting right on the nearest support level at $137.19 and 19% above its range low. The stock is deeply sold off — 56% below its range high and well under both the 50-day and 200-day averages ($148 and $173) — which matches the idea's argument that the selloff is macro-driven rather than a demand problem, per the idea's thesis. However, this is a watch-list setup, not an active signal. The entry requires a coordinated sequence: the 14-day RSI crossing below 30 and then back above 40, price crossing below and then reclaiming the 50-day EMA, price above the 200-day EMA, and QQQ holding at or above its own 50-day EMA. Right now only part of the picture is in place: ORCL's RSI is 31.7, still above the 30 threshold by 1.7 points, price is about $11 below the 50-day EMA and about $36 below the 200-day EMA, while QQQ is already satisfied at $744.50 versus its $717 EMA. Until all conditions line up, the disciplined move is to wait — no partial entries. Once triggered, the strategy defines risk mechanically: a fixed stop at negative 2.5% of entry, a take profit at plus 4.9%, a resistance-based exit near $149, and a 60-day time stop. That is roughly a 2-to-1 reward-to-risk on the fixed brackets, with position size capped at 25% of the account and sized to risk about 2.5% per trade. If the entry never arms, waiting costs nothing — the plan is complete only when every condition fires together.

The Earnings Machine Is Accelerating — Even If the Entry Hasn't Fired Yet

The idea's core claim — that Oracle's AI and cloud demand is intact and the US share-price weakness is macro, not fundamental — gets real support from the latest reported quarter. For the three months ended August 31, 2026, revenue came in at $19.35B, up 20.6% year over year and ahead of the prior quarter's $19.18B. That growth rate puts Oracle at roughly the 75th percentile among nearly 900 Information Technology peers — for a company this size, growing one-fifth per year is the acceleration story the idea is leaning on. Profitability backs it up. Operating margin expanded 2.8 percentage points quarter over quarter to 34.8%, which sits at the 97th percentile of the sector. Net income jumped 13.3% to $4.76B and net margin improved to 24.6%. Operating cash flow surged 58% sequentially to $23.1B in the August quarter. These are not the numbers of a business whose demand is cracking — they are the numbers of a business spending aggressively to meet demand. The balance sheet trajectory also matters for the bull case. Debt-to-equity, which peaked at an extreme 84.3x in fiscal 2023, has been brought down steadily — to 9.98x in fiscal 2024, 4.53x in fiscal 2025, and 3.05x in fiscal 2026. Management has deleveraged while simultaneously funding capex, and the dividend history shows confidence: the trailing twelve-month payout has climbed to $2.00 per share, with annual growth of 11.1% and the most recent $0.50 payment going ex on July 10, 2026. The cited news…

Scores

• Conviction score breakdown: 48
• Thesis support: 65
• Trade readiness: 30
• Risk quality: 50
• Trigger proximity: 25
• Fundamentals trend: 70

Watch items

• ORCL — RSI (14)
• ORCL — Close vs EMA (50)
• ORCL — Close vs EMA (200)
• QQQ — Close vs EMA (50)
• ORCL — Free cash flow (quarterly)
• ORCL — Insider net open-market activity
• ORCL — Dividend ex-date
• ORCL — Nearest resistance